ID19050A - Turunan-turunan asam karboksilat yang baru, pembuatannya dan penggunaannya - Google Patents

Turunan-turunan asam karboksilat yang baru, pembuatannya dan penggunaannya

Info

Publication number
ID19050A
ID19050A IDP971240A ID971240A ID19050A ID 19050 A ID19050 A ID 19050A ID P971240 A IDP971240 A ID P971240A ID 971240 A ID971240 A ID 971240A ID 19050 A ID19050 A ID 19050A
Authority
ID
Indonesia
Prior art keywords
carboxicate
drivings
manufacture
acid
new
Prior art date
Application number
IDP971240A
Other languages
English (en)
Indonesian (id)
Inventor
Wilhelm Amberg
Andreas Kling
Dagmar Klinge
Hartmut Riechers
Ernst Baumann
Liliane Unger
Manfred Raschack
Stefan Hergenroder
Sabine Schult
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of ID19050A publication Critical patent/ID19050A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IDP971240A 1996-04-12 1997-04-14 Turunan-turunan asam karboksilat yang baru, pembuatannya dan penggunaannya ID19050A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19614542A DE19614542A1 (de) 1996-04-12 1996-04-12 Neue Carbonsäurederivate, ihre Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
ID19050A true ID19050A (id) 1998-06-04

Family

ID=7791123

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP971240A ID19050A (id) 1996-04-12 1997-04-14 Turunan-turunan asam karboksilat yang baru, pembuatannya dan penggunaannya

Country Status (23)

Country Link
US (1) US6103732A (zh)
EP (1) EP0892788A1 (zh)
JP (1) JP2000508325A (zh)
KR (1) KR20000005366A (zh)
CN (1) CN1216042A (zh)
AR (1) AR006593A1 (zh)
AU (1) AU711293B2 (zh)
BG (1) BG63202B1 (zh)
BR (1) BR9708614A (zh)
CA (1) CA2250764A1 (zh)
CO (1) CO4900038A1 (zh)
DE (1) DE19614542A1 (zh)
HR (1) HRP970200A2 (zh)
ID (1) ID19050A (zh)
IL (1) IL126026A0 (zh)
NO (1) NO311802B1 (zh)
NZ (1) NZ331704A (zh)
PL (1) PL329240A1 (zh)
SK (1) SK127698A3 (zh)
TR (1) TR199802042T2 (zh)
TW (1) TW419465B (zh)
WO (1) WO1997038982A1 (zh)
ZA (1) ZA973096B (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2275256A1 (en) 1996-12-18 1998-06-25 Basf Aktiengesellschaft Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists
US6030975A (en) * 1997-03-14 2000-02-29 Basf Aktiengesellschaft Carboxylic acid derivatives, their preparation and use in treating cancer
JP2001514254A (ja) * 1997-09-04 2001-09-11 ビーエーエスエフ アクチェンゲゼルシャフト 新規カルボン酸誘導体、その製造及び混合eta/etbエンドセリン受容体拮抗薬としてのその使用
EP1023067B2 (en) * 1997-10-17 2011-08-24 Ark Therapeutics Limited The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
US7566452B1 (en) 1999-05-04 2009-07-28 New York University Cancer treatment with endothelin receptor antagonists
DE60120104T2 (de) * 2001-03-20 2006-09-21 Schwarz Pharma Ag Neue Verwendung von Peptidverbindungen bei der Behandlung von nicht-neuropathischem Entzündungsschmerz
EP1243263B1 (en) * 2001-03-21 2002-11-27 Schwarz Pharma Ag Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain
WO2005099740A1 (en) 2004-04-16 2005-10-27 Schwarz Pharma Ag Use of peptidic compounds for the prophylaxis and treatment of chronic headache
BRPI0514721A (pt) * 2004-08-27 2008-06-24 Sanol Arznei Schwarz Gmbh uso de compostos de peptìdeos para tratar dor de cáncer ósseo, dor induzida por quimioterapia e nucleosìdeo
US20070043120A1 (en) * 2005-08-18 2007-02-22 Bettina Beyreuther Therapeutic combination for painful medical conditions
EP1754476A1 (en) * 2005-08-18 2007-02-21 Schwarz Pharma Ag Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia
US20070048372A1 (en) * 2005-08-18 2007-03-01 Srz Properties, Inc. Method for treating non-inflammatory osteoarthritic pain
TWI397417B (zh) 2006-06-15 2013-06-01 Ucb Pharma Gmbh 具有協同抗驚厥功效之醫藥組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996000219A1 (en) * 1994-06-27 1996-01-04 Ciba-Geigy Ag Pyrimidinyl- and triazinyl-oxy and thio-3-haloalkyl-propionic acid derivatives as herbicides

Also Published As

Publication number Publication date
CO4900038A1 (es) 2000-03-27
TR199802042T2 (xx) 2000-09-21
DE19614542A1 (de) 1997-10-16
TW419465B (en) 2001-01-21
BR9708614A (pt) 1999-08-03
KR20000005366A (ko) 2000-01-25
NO311802B1 (no) 2002-01-28
WO1997038982A1 (de) 1997-10-23
CN1216042A (zh) 1999-05-05
PL329240A1 (en) 1999-03-15
ZA973096B (en) 1998-10-12
EP0892788A1 (de) 1999-01-27
NO984713D0 (no) 1998-10-09
NO984713L (no) 1998-10-09
IL126026A0 (en) 1999-05-09
NZ331704A (en) 2000-06-23
JP2000508325A (ja) 2000-07-04
AU2636497A (en) 1997-11-07
CA2250764A1 (en) 1997-10-23
AU711293B2 (en) 1999-10-07
AR006593A1 (es) 1999-09-08
SK127698A3 (en) 2000-03-13
BG63202B1 (bg) 2001-06-29
HRP970200A2 (en) 1998-04-30
US6103732A (en) 2000-08-15
BG102770A (en) 1999-11-30

Similar Documents

Publication Publication Date Title
ID17016A (id) Turunan-turunan asam yang baru dan penggunaannya sebagai penghambat-penghambat trombin
ID22426A (id) Ketobenzamida yang baru dan penggunaannya
ID18925A (id) Penggunaan benzazol-benzazol yang disubstitusi sebagai absorben-absorben uv, benzazol-benzazol baru dan proses-proses untuk pembuatannya
ID22490A (id) Benzamida-benzamida yang disubstitusi secara heterosiklik yang baru dan penggunaannya
ID23557A (id) Poliester baru dan proses pembuatan poliester
ID21781A (id) Benzamidoaldehida baru dan penggunaannya
ID26305A (id) Benzamida tersubstitusi baru, pembuatan dan penggunaannya
ID18421A (id) Pembuatan asam akrilat dan asam metakrilat
ID19290A (id) Turunan-turunan propiofenon dan proses pembuatannya
ID19479A (id) Turunan-turunan amidino baru dan pemakaian sebagai penghambat-penghambat trombin
ID16044A (id) Pemurnian asam akrilik dan asam metakrilik
DE69408679D1 (de) Herstellung von geformten faserstrukturen
ID25469A (id) Komposisi sefalosporin amorf yang stabil secara kristalografi dan proses pembuatannya
ID16079A (id) Poliisosianat terblok baru dan penggunaanya
ID27126A (id) Proses pembuatan garam-garam asam karboksilat dan katalis-katalis yang berguna dalam proses tersebut
ID27558A (id) Amida-amida aromatik baru, metode pembuatannya dan penggunaannya sebagai obat
ID19050A (id) Turunan-turunan asam karboksilat yang baru, pembuatannya dan penggunaannya
ID16824A (id) Turunan-turunan asam karboksilat yang baru, pembuatan dan penggunaannya
ID20137A (id) Turunan propanolamina, proses pembuatannya, sediaan farmasi yang mengandung senyawa ini, dan penggunannya
ID20855A (id) Senyawa turunan imidazolidin baru, pembuatannya, penggunaannya dan sediaan farmasi yang mengandung senyawa tersebut
ID22911A (id) Turunan-turunan triazol baru, proses pembuatan dan komposisi-komposisi farmasi yang mengandungnya
ID17199A (id) Mikro-organisme pengurai hidrokarbon yang mengandung halogen dan pemakaiannya
ID18425A (id) Pembuatan asam akrilat dan asam metakrilat
ID23990A (id) Komposisi-komposisi pencuci asam yang mengandung amina-amina teralkoksilat dan penggunannya
ID24283A (id) Turunan-turunan asam karboksilat baru, pembuatannya dan penggunaannya dalam pengobatan kanker